Patents by Inventor Thomas M. WILKIE

Thomas M. WILKIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Screen and use of therapeutics for pancreatic ductal adenocarcinoma
    Patent number: 9986723
    Abstract: The present disclosure relates to methods for screening compounds for treating pancreatic ductal adenocarcinoma (PDA) using a mouse model with an Rgs16::GFP reporter. Also described are combination therapies for treating pancreatic ductal adenocarcinoma (PDA) using taxanes, gemcitabine and an Axl kinase inhibitor.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: June 5, 2018
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Thomas M. Wilkie, Rolf A. Brekken
  • SCREEN AND USE OF THERAPEUTICS FOR PANCREATIC DUCTAL ADENOCARCINOMA
    Publication number: 20160128311
    Abstract: The present disclosure relates to methods for screening compounds for treating pancreatic ductal adenocarcinoma (PDA) using a mouse model with an Rgs16::GFP reporter. Also described are combination therapies for treating pancreatic ductal adenocarcinoma (PDA) using taxanes, gemcitabine and an Axl kinase inhibitor.
    Type: Application
    Filed: October 22, 2015
    Publication date: May 12, 2016
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Thomas M. WILKIE, Rolf A. BREKKEN